Large differences in dialysis access exist between Europe, Canada, and the United States, even after adjustment for patient characteristics. Vascular access care is characterized by similar issues, but with a different magnitude. Obesity, type 2 diabetes, and peripheral vascular disease, independent predictors of central venous catheter use, are growing problems globally, which could lead to more difficulties in native arteriovenous fistula placement and survival. Creation of dedicated dialysis access teams, inc1uding a vascular access coordinator, is a fundamental step in improving vascular access care; however, it might not be sufficient. The possibility that factors other than patient characteristics and surgical skills are important in determining outcomes is likely; it might explain apparent contradictions of end-stage renal disease (ESRD) practices (kidney transplant, peritoneal dialysis, patterns of vascular access use in hemodialysis), where some countries excel in one area and score poorly in another. We are on the same path, but we have a lortg way to go.
designated by the Centers for Medicare and Medicaid Services (CMS), use of fistulas ranged from 25.4 to 53.4%.
In 2002, the first series of data was published on vascular access from the Dialysis Outcomes and Practice Patterns Study (DOPPS). 3 One of the goals of this prospective, longitudinal study of hemodialysis (HD) practices and associated outcomes was to examine vascular access use in the United States and in five European countries (France, Germany, Italy, Spain, and the United Kingdom [UK.]). Facilities and patients were se1ected to provide nationaliy representative samples of the HD population in each country. The same data coHection protocol was used in ali countries allowing a direct comparison of outcomes across countries and types of facilities. In Europe, A VF accounted for 80% of aH accesses, with 10% of patients using grafts. High A VF use was seen in aH five European countries, ranging from 67% in the U.K. to 90% in Italy. In contrast, grafts were the predominant access type in the United States, comprising 58% of aH accesses, with only 24% of US. patients using an A VF. Catheter use was 17% in the United States compared with 8% in Europe. The main finding of the study was that the facilities preferences and approaches to vascular access practice are major determinants of vascular access use, justif}ring, in part, the large differences in clinical practice found between Europe and the United States. However, the studyalso demonstrated significant differences in··patient characteristics, Fig. 1 iHustrates a representative US. patient with extreme deterioration of vesse1s, not uncommon in U.S. vascular access clinics and very rare in European renal units. US. patients were more like1y diabetic (46% versus 22% of the population), affected by peripheral vascular disease (23% versus 19%), with a heavier history of angina pectoris (37% versus 25%). In addition, US. patients had a higher number of females (47% versus 43%), a higher mean body mass index (BMIj 25.1 ±5.9 versus 24.1 ± 4.7 kg/m2), and a shorter dialysis vintage over, AVG use fell by 50% in the United States from 58% use in 1996 to 28% by 2007. Catheter use rose 1.5-to 3-fold among prevalent patients, even if nondiabetic. Furthermore, 58 to 73% of incident patients used a catheter for the initiation ofHD in five countries despite 60 to 79% of patients having been seen by a nephrologist more than 4 months prior to ESRD. Patients were significantly less like1y to start dialysis with a permanent vascular access (VA) if treated in a facility that had a longer time from referral to access surgery evaluation or from evaluation to access creation. Longer times from access creation until first AVF cannulation were associated with higher catheter use as welI. Across three phases of data collection, patients consistently were less like1y to use an A VF versus other VA types if female, of older age, having greater BMI, diabetes, peripheral vascular disease, or recurrent ceHulitis/gangrene. In addition, countries with a greater prevalence of diabetes in HD patients had a significantly lower percentage of patients using an A VF. 1 T o better assess similarities and differences among different countries in the fie1d of dialysis access, we summarized in Table 1 information derived from different studies. 1, [4] [5] [6] [7] [8] It appears that specific country-re1ated and facility-re1ated factors have a major influence in the choice of dialysis accessoAccording to our ideaI approach 4,5,6,7,8. to advanced chronic kidney disease (CKD) treatment (Table 2) , the best health system should have a high prevalence of transplanted patients, peritoneal dialysis patients, and, among patients treated by HD, a high rate of native A V fistula as vascular accesso As we can see from Table 1 , ]ar,an has the best prevalence of A VF and very good survival rates, but very low peritoneal dialysis (PD) and transplant rates. Germany has the lowest prevalence of CVC in Europe, but their performance in PD is the worst. Canada and Why do Italian patients have a high prevalence of AVF? We believe that the main reason is the fact that when the first dialysis units were opened, difficulties arose in finding dedicated vascular surgeons and giving adequate priority to dialysis access surgery. In a rather unique way, nephrologists, who in some cases had a surgical background as urologists or transplant surgeons, started performing vascular access surgery, creating a situation where ti me from diagnosis of ESRD to access surgery was kept at the minimum and the nephrologist-surgeon knew the problems linked to access use, especially cannulation issues. In addition, the presence of a National Health System alIowed time1y referral from the generaI practitioner to the nephrologist. In some way, a primitive dialysis access team was already in action, alI of it inside the same renal unito Then, the figure of the nephrologistsurgeon grew and in some cases reached high leve1s of skilI, while several dedicated vascular and transplant surgeons solved the most difficult cases of vascular access creation and revision, becoming second-Ievel speciaIized access surgeons with great experience.12 Interestingly, because in Italy only certified radiologists can work with x-ray machines, vascular interventional nephrology did not deve10p with the same ease; therefore, most renal units developed a collaboration with an interventional radiologist, with the exception of colar Doppler ultrasonography-guided . l 13 anglOp asty.
Why so many catheters in Canada? Canada has a national health system, but the pattern of vascular access distribution is much different from Italy. This is in striking contrast with the excellent penetration of the PD technique, which may be favored by patients when they live far away from a HD unito Two recent studies addressed this problem.14.15 Mende1ssohn et aI14 anaIyzed data from the DOPPS study, reporting that even though 85% of Canadian patients had been seen by a nephrologist far more than 1 month prior to starting dialysis, CVC use was 33% in prevalent patients and 70% in incident patients, cont\:ilry to the preferences of Canadian dialysis clinic medicaI directorso A possible reason far this discrepancy is the Iength of time from referral untii permanent vascular access creation (61.7 days compared with 29.4 days in Europe or 16 days in the United States). In turn, this longer de1ay time may be a consequence of the lower number of access surgeons in Canada compared with the United States and some European countries. In a situation similar to that faced by Italian nephrologists, Canadians did not have the opportunity to start surgicai activity in vascular access, while it is common practice far a nephrologist to insert a tunneled catheter. Graham et al15 found a significant influence of duration of HD on the type of accesso In patients within 6 months of HD initiation, there was a very high prevalence of CVC use (75%), but as dialysis vintage increased, the prevalence of CVC use decreased progressively, reaching a low of 21.3% in patients after 5 years of HD. System/resource limitations accounted far the highest percentage of factors influencing the choice of CVC as HD access within the first 6 months ofHD (54.8%), compared with only 8.6% of factors influencing access choice in patients on HD beyond 5 years. This institution has a dedicated dialysis access team and allocated operating room time far access creation; however, there are a limited number of access surgeons avaiIable.
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Nonetheless, only 10.5% of patients with CVC were awaiting A VF ereation, revision, or maturation; 28.2% of patients with system /resource Iimitations influencing CVC choice were either awaiting assessme n! far peritoneaI diaIysis, undecided about modality choiCe, or awaiting transplant. Vascular issues accounted far the majority of factors influencing CVC use (47.1% of patients), whereas poor cardiac status influenced decision making in 8.8% of patients. The authors concluded that patient-specific factors (vascular factors and medicaI contraindications) are the predominant influences on CV catheter use in their prevalent HD . Although outcomes of vascular access are stilI better in Europe, a clear change in clinical policies is taking pIace in the United States, with significant results and an improved pro file of vascular access use. The Fistuia First Breakthrough Initiative, whose goal is to ensure that every patient receiving HD has the opportunity to have a native AVF as the optimal vascular access where feasibIe, certainIy contributed to such an improvement.8,17 SimiIarly, the Netherlands, a country with one of the Iowest A VF rates in Europe, fostered the CIMINO initiative,18 a multicenter guideIines implementation program, which promoted an increase in the number of AVFs and a decrease in untunneled catheters. This was counterbalanced by an increase of tunneled catheters, indicating that the choice of access placement depends predominantly on center-specific factors.
Thus, we-Europeans and Americans aIike-are indeed on the same path and have the same goaIs.
A DIAL YSIS ACCESS ALGORITHM
In keeping with the idea of sharing experiences and improving the outcomes of diaIysis access, we recently described a diaIysis access algorithm approach to the patient needing renaI replacement therapy, considering Iong-term improved patient outcome as the ultimate objective. 19 In the ideaI world (Table 2) , the impending renal failure diagnosis is proactively managed with a RADIOLOGY /VOLUME 26, NUMBER 2 2009 preemptive living donor kidney transplant or by the timely creation of the best (PD or HD) dialysis access for the individuaI patient. However, because of patient denial and late consideration for dialysis access placement, and sometimes because of organizational pitfalls of nephrologic and surgical facilities, the reality is plagued by the fact that many patients initiate HD with a dual lumen catheter. On the other hand, in situations where timely and accurate education is given to the patient with advanced CKD, a significantly higher number of patients (40%) choose PD and only a small fraction start HD with a temporary catheter. 20 We believe that high-quality patient education and adequate vascular access planning and management can be achieved only with a teamwork approach, representing a continuum of care treatment model of the ESRD patient, where emphasis is placed on team members being in dose proximity and ideally in the same clinic.2l This allows timely decision making from the surgeon, the nephrologist, and the interventional radiologist ("pit-stop approach"). This concept also implies clear and effective communication between team members with emphasis on patient safety, outcome, and comfort.
A dialysis access short-and long-term pIan should be updated on a regular basis. With a proactive approach, future access problems can be anticipated and addressed with the overall goal to avoid dialysis interruptions with temporary centraI vein catheter and associated morbidity.
•.
HOW TO IMPROVE THE OUTCOME OF DIAL YSIS ACCESS
Two seemingly simple measures would dramatically improve the outcome of future dialysis access: early referral and vein preservation. Other factors that would promote a higher prevalence of native A VFs are the use of microsurgery; extensive use of vessel mapping to identif)r suitable vessels for surgery and the pr~sence of stenosis/thrombosis of centraI veins; building a wellorganized dialysis access team, including a dialysis access coordinatori improving surgeon education and training in dialysis access surgery, especially transposition and other more complex A VFs; improving staff cannulation skills; and improving infection rates. Performing dialysis at lower blood flow rate, but in longer dialysis sessions to keep dialysis effective, might also be a reason why Europeans can maintain a failing access for enough time to avoid the use of a catheter while preparing a new accesso
Early Referral
Early referral to a nephrologist and to an access surgeon for evaluation increases the likelihood for placing a native vein AVF and avoiding morbidity from a temporary catheter placement. 22, 23 Indeed, starting dialysis with a permanent A V access is associated with improved survival of the access itself, compared with patients whose A VF or A ve has been placed after the start of dialysis. However, it should be kept in mind that DOPPS I data showed that most (55%) of the 46% of U.S. patients starting dialysis with a venous catheter was seen by a nephrologist more than 30 days prior to ESRD. Similarly, the problem of incident patients starting dialysis without a permanent access placed during CKD was also relevant in European patients: 56% of them had seen a nephrologist more than 30 days prior to ESRD.3 Therefore, both in Europe and in the United States, the situation could be improved with a better understanding of factors determining the lack of a permanent access in patients seen by a nephrologist more than 30 days before the start of dialysis.
Vein Preservation
Preserving veins by preventing venipunctures and intravenous (IV) lines in potential dialysis access veins for A VF placement also increases the chances for native vein A VF. There is much abuse of potential A VF veins from IV lines and blood draws. Only the dorsal aspect of the hand should be allowed for venous blood accessoPatients undergoing HD can have blood draws done during dialysis treatment to preserve veins. PICC lines (peripherally inserted centraI catheters) must not be used in patients with a future dialysis need, and certainly not in stage 4 to 5 ESRD patients.
Microsurgery
Microsurgery appears to offer significant advantages in A VF creation, improving immediate success and longterm patency, as reported in the most difficult dialysis population, children.24 It implies the use of a surgical microscope, microsurgical instruments, prophylactic hemostasis, and no-touch surgery. Using this approach, Bourquelot et al25 reported the outcomes of dialysis A V access microsurgery in 380 children: the ratio AVF/AVe was 93%/7% and the creation of a distaI A VF was possible in 78% of the children. The immediate patency rate was 96% and only 10% of AVF failed to mature. Re m arkably, the 24-month patency rate was 85% in distaI radial-cephalic AVF, 72% in brachial-basilic AVF, 47% in brachial-cephalic AVF, while A ve patency was only 5%. The French experience may be difficult to duplicate in different settings, but the excellent results reported with this approach should be seriously considered now that patient characteristics are deteriorating and an increased number of catheters is being used in most countries. 159 HD patients with mature AVFs whether adding access blood flow surveillance to clinical monitoring (combined with e1ective stenosis repair) reduces thrombosis and access loss rates. They found that adding access blood flow surveillance to clinical monitoring is associated with a better detection and e1ective treatment of stenosis, a 73% reduction in thrombosis rate, 86% reduction in CVC placements, 65% reduction of access loss, with a concomitant reduction of global accessrelated costs, although the cumulative access patency was only extended in the first 3 years after fistula maturation. Thus, access blood flow surveillance, when coupled with preemptive intervention, reduces the thrombosis rate in A VF, suggesting that the functional access life can be prolonged.
The Dialysis Access Team
Effective dialysis access care can be better achieved by a systematic management, involving the patient, dialysis staff, clinical and interventional nephrologists, interventional radiologists, and access surgeons. Team-building efforts will increase people's effectiveness and satisfaction, improve patient outcomes, and reduce costs as summarized in Table 3.29 Such an approach was first described~1O years ago.30, 31 Becker et aeo demonstrated that by implementing a vascular access care pathway, emphasizing coordinated patient evaluation and outpatient surgery, improved outcomes associated with vascular access surgery, including costs and length of hospital stay, with a better patient satisfaction. A1lon et a131 described the deve10pment of a multidisciplinary approach, involving nephrologists, access surgeons, and radiologists. A fulltime dialysis access coordinator scheduled all access procedures with the surgeons and radiologists, and Vessel Mapping Vesse1 mapping is of paramount importance in planning and obtaining a successful vascular access. 26 A pertinent patient history and physical examination are important first steps in assessing the course of action, both prior to access placement and when evaluating an established access with problems. These basic evaluations direct decisions on more expensive and often invasive testing. A carefully performed history and physical exam will yie1d proper patient se1ection for the most optimal dialysis modality and site of access placement. A pertinent history includes type and nature of past access procedures (especially catheters, name1y CVC and PICC lines) and pacemakers, breast and axillary dissection surgery, chest radiation, and emergency vascular cut-downs. Physical examination includes a detailed search for veins in both upper extremities starting with the forearm cephalic and basilic veins. Vascular examinatio n must assess both the arterial and the venous system, through inspection and palpation. Visible veins are marked with an indelible pen to guide Doppler ultrasound examination (DUE), which is often used to confirm or correct the initial impression based on history and physical examination, and to define surgical and interventional anatomy. DUE is the most cost-effective noninvasive test for dialysis access planning. Nearly all patients requiring dialysis access should undergo DUE examination. The quality of the DUE is operator dependent. Ideally, the surgeon should be presct'lt to direct the sequence of examination steps and mark the skin, documenting vesse1 size, intended surgery sites, and anatomic variations. The specific features assessed during DUE of the venous system, the arterial system, and of dialysis access grafts can be found in our previous publication.26 DUE can also be used to assess blood flow problems associated with established HD accesso It will confirm the clinical diagnosis and direct the treatment in the majority of cases. In a more complex access situation, invasive imaging technology such as a fistulogram is warranted. DUE and IV contrast fistulogram are-not competitive but complementary. In most instances, when DUE examination suggests pathology, a fistulogram with simultaneous interventional treatment is indicated.
Access blood flow measurement, followed by the correction of hemodynamically significant stenoses to prolong access survival, is the recommended method for A VF surveillance for stenosis, but whether it may be benefici al and cost-effective is controversia1.27 Access blood flow measurement allows an accurate identification of A V accesses at risk of failure, with an access blood flow less than 700 to 1000 mLimin and/or a reduction in flow more than 25% as optimal predictors for stenosis. Access blood flow less than 400 mL/min suggests incipient thrombosis. Recently, Tessitore et aes evaluated in a 5-year controlled, nonrandomized study on tracked outcomes. A computerized database was used for prospective documentation of procedures and complications. Confidential, detailed analyses and recommendations far improvements were provided periodicalIy to the surgeons and radiologists. After the implementation of this multidisciplinary care, the approach to clotted grafts evolved from an inpatient surgical procedure to an outpatient radiologic procedure, with an increase of immediate technical success rate of graft declots from 48 to 69%; e1ective placement of AVG evolved from a 3-day inpatient hospitalization to a large1y outpatient procedure; surgical complications of new AV graft surgery decreased from 25% to 11%; aggressive detection and correction of graft stenosis decreased the incidence of graft thrombosis by 60%; and the proportion of native A VF construction in new dialysis patients increased from 33 to 69%. This study also confirms that an integrated multidisciplinary approach can reduce surgical complications of access surgery and decrease access failures, with a concomitant decrease in hospitalization for access procedures and a substantial cost saving.
Subsequently, the DOPPS I study also pointed out that an important aspect of incident HD patients care is the process and organizational structure of the referral network for placing vascular accesses.3 A fast process of less than 2 weeks from time of referral until access placement was associated with a 1.8-fold higher like1ihood of new ESRD patients beginning HD with a 02 permanent vascular accesso More recently, Flu et alJ showed that the implementation of a bimonthly multidisciplinary meeting in vascular access surgery (with the presence of the vascular surgeons, nephrologists, interventional radiologists, dialysis nurses, and the ultrasound technicians) optimized the timing, indication, type of intervention, and the logistics of A V access management during the preoperative and postoperative periodo Importantly, a significant increase in endovascular balIoon angioplasties and a significant decrease in surgical revisions were observed, resulting in less patient morbidity. Arso, higher primary and secondary patency was achieved after the introduction of the new optimized care protocol.
Dialysis Access Coordinator
A dedicated dialysis access coordinator (or dialysis access manager) can greatly increase the efficiency of dialysis, by maintaining a comprehensive database of access procedures and their short-term and long-term complications (including infections), monitoring and directing communications between alI the involved parties, assuring that access screening is proper1y performed, and arranging far time1y evaluations and interventions. The experience with transplants clear1y demonstrated that a transplant coordinator improves transplant outcomes, and dialysis access management should give similar results in improving A VF prevalence. In summary, the dialysis access coordinator assesses and identifies the vascular access needs of patients; procures, de1ivers and coordinates services for the patient in the outpatient and hospital setting; provides for ongoing monitoring of the patient' s vascular access to assure adequate dialysis is obtained and maximum life of the access is achieved; and plans for future intervention, if necessary. An Australian group33 recently confirmed the effectiveness ofintroducing a dialysis access coordinator in the renal unit. They demonstrated that after a situational analysis showed poor overall coordination of surgical waiting lists, multifaceted intervention, including the introduction of a vascular access nurse coordinator and an algorithm to prioritize surgery, significantly increased the proportion of patients starting HD therapy with an A VF from 56 to 75%,_with a concomitant 40% reduction in catheterdays.
Improving Surgeon Education and Training in Dialysis Access Surgery
More data from the DOPPS alIow some considerations on the issue of appropriate surgical training in dialysis Risk of primary fistula failure was 34% lower when placed by surgeons who created 25 or more (versus less than 25) AVFs during training. Therefore, the authors concluded that surgical training is key to both fistula placement and survival, yet D.S. surgical programs seem to pIace less emphasis on fistula creation than those in other countries, underscoring the importance of enhancing surgical training in A VF creation.34
Improving Cannulation Skills
One important issue is the timing of cannulation after A VF surgery. Rayner et al35 showed that cannulation before 14 days of A VF life was associated with a 2.1-fold increased risk of subsequent A VF failure compared with AVF cannulated after 14 days, while no significant difference in A VF failure was seen for A VF used in 15 to 28 days compared with 43 to 84 days. Accordingly, AVF ideally should be left to mature for at least 14 days before fìrst cannulation. Another relevant issue is cannulation technique, specifìcally the potential advantages of the buttonhole versus the standard ropeladder technique. 36 The buttonhole technique, cannulation of exactly the same site, offers the advantage of an easy cannulation procedure. However, it can be used only in native fìstulas and cannulation is preferably executed by a "single-sticker." A comparison of the two techniques in 33 self-cannulating home HD patients with a native arteriovenous fìstula was undertaken, prospectively observing for 18 months cannulating ease, number of bad sticks, pain, time of compression after needle removal, bleeding, infectious complications, and aneurysm formation. With the buttonhole method, cannulating ease improved distinctly; this was especially favorable in patients with a short fìstula vein. Reported cannulation pain did not change signifìcantly. The incidence of bad sticks decreased signifìcantly, as well as ti me of compression after needie removal, without increased incidence of bleeding. Three patients developed a Iocai skin infection of their buttonhole during the study, which determined a change in the disinfection routine prior to cannuiation. Thus, the buttonhole method seems to improve cannuiating ease avoiding the possibie formation of aneurysms, but precautions have to be taken to prevent infectious complications. Indeed, Doss et ae7 also suggested that the infection rate with the buttonhole method of needie insertion may be underestimated.
Improving Infection Rates
The vascular access site is the most common site for infection in HD patients, and access site infections are particularly important because they can cause loss of the vascular access and disseminated bacteremia; they also account for r--; 15% of deaths in diaIysis patients. The primary risk factor for access infection is the access type, with CVC having the highest risk, A ve intermediate, and A VF the Iowest risk of infection. The incidence of vascular access related infections is 1.3 to 7.2/100 patient months in the United States and 3.2 to 5.7/100 patient months in Europe.
A recent 8-month observationai prospective study on nosocomial bacterial infections in dialysis patients was conducted in 19 renai units in Piedmont, Northern Italy. 38 Results have been compared with data from a US. infection surveillance network. Considering all access-related infections, Ferrero et ae8 found incidence rates of 1.47/100 patient months, compared with 3.22/ 100 patient months in the United States. Interestingly, when considering Iocai infections results were similar (1.34 versus 1.43/100 patient months, respectively), whereas systemic infections differed markedIy (0.19 versus 1.78/100 patient months). In tunneled catheters, the difference in the rate of systemic infections was 0.76/ 100 patient months in Piedmont versus 4.84/100 patient months in the United States. This difference might be due to more accurate CVC handling in Italian dialysis units, where the opening and closure of a CVC are usually performed aseptically by two operators, and at least one of them is a certifìed nurse.
CONCLUSIONS
Vascular access care in diaIysis patients from different countries is characterized by similar issues, although with different magnitude. Obesity, of epidemic proportions in the United States, is aiso a growing probIem globally, which could cause more diffìculties in native A VF creation. The same consideration applies to type 2 diabetes, which is a growing probIem as well. Peripheral vascular disease appears to be a previously underestimated independent predictor of CVC use.
Creation of dedicated diaIysis access teams, including a vascular access coordinator, is in our view a fundamentai step in improving vascular access care.
Social issues, system and resource limitations, and patient-specifìc factors (vascular factors and medicaI contraindications) may influence decision making in the choice of A V access versus CVC. Thus, it is possible that an incrt;,tlse in CVC use will occur if the diaIysis population continues to age and deteriorate clinically, uniess more aggressive care and A V surgery activity are undertaken before the start of diaIysis.
Important differences still exist among Europe and the United States, as demonstrated by the recent A VF DAC Study,39 which showed that in the United States 20 to 50% of fìstulas do not mature adequately for use, and that early A VF failure is a major barrier to increasing fìstuia prevalence, proionging catheter use. Such fìgures raised surprise among European nephrolo-. d d' l . 40 glStS an la YSlSaccess surgeons. The possibility that factors different from patients characteristics and surgical skills are important in determining outcomes is Iikely, and it might expIain the apparent contradiction ofESRD practices (kidney transpiant, peritoneal dialysis, patterns of vascular access use in HD), where some countries excel in one area and score poorly in another. We join many other physiciansresearchers in advocating more randomized triais and appropriate epidemioiogicai studies to improve evidence-based care of diaIysis patients and their vascular accesso
